The government of Colombia has issued its first-ever compulsory license to enable access to generic versions of the key HIV medicine dolutegravir, without permission from the patent owner, ViiV Healthcare. Dolutegravir is recommended as part of the preferred first-line antiretroviral treatment regimen for people living with HIV, including during pregnancy, as per the guidance of […] Continue reading ->
The US plans to double the number of countries it supports to prevent infectious disease outbreaks, opting for bilateral agreements with at least 100 countries, according to its new Global Health Security Strategy (GHSS). “Recent outbreaks, from mpox to Marburg, cholera, and other diseases… are wake-up calls for anyone who thought COVID was a once-in-a-lifetime […] Continue reading ->
Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all.  A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading ->
A team of researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford have identified diabetes, traffic-related air pollution exposures and alcohol use as the most harmful out of 15 modifiable risk factors for dementia. Their paper, published last month in Nature Communications, examines how genetic traits and modifiable risk factors affect […] Continue reading ->
The World Bank aims to support countries to deliver “quality, affordable health services” to 1.5 billion people by 2030, it announced during its ‘spring’ meeting in Washington this week. It will expand its current focus from maternal and child health to include “coverage throughout a person’s lifetime, including non-communicable diseases”; hard-to-reach areas, including remote villages, […] Continue reading ->